We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+13.63%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$48.3B
AUM Growth
+$4.2B
Cap. Flow
-$749M
Cap. Flow %
-1.55%
Top 10 Hldgs %
25.22%
Holding
973
New
114
Increased
273
Reduced
385
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 25.57%
2 Healthcare 16.39%
3 Financials 11.55%
4 Consumer Discretionary 10.38%
5 Industrials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RZLT icon
776
Rezolute
RZLT
$453M
$627K ﹤0.01%
631,690
BNTC icon
777
Benitec Biopharma
BNTC
$451M
$611K ﹤0.01%
189,188
IMA
778
ImageneBio Inc
IMA
$64M
$567K ﹤0.01%
23,992
-10,000
-29% -$326K
BOLT icon
779
Bolt Biotherapeutics
BOLT
$7.44M
$560K ﹤0.01%
25,000
LBRT icon
780
Liberty Energy
LBRT
$3.27B
$544K ﹤0.01%
30,000
-689,795
-96% -$13.1M
RPID icon
781
Rapid Micro Biosystems
RPID
$104M
$518K ﹤0.01%
700,000
GTHX
782
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$458K ﹤0.01%
+150,000
New +$282K
NGMS
783
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$392K ﹤0.01%
+13,700
New +$371K
CMRX
784
DELISTED
Chimerix, Inc.
CMRX
$385K ﹤0.01%
400,000
LNZA icon
785
LanzaTech
LNZA
$68M
$373K ﹤0.01%
743
KITT icon
786
Nauticus Robotics
KITT
$7.32M
$250K ﹤0.01%
142
+49
+53% +$187K
CBIO
787
Crescent Biopharma
CBIO
$610M
$236K ﹤0.01%
+1,000
New +$155K
IVCBW
788
DELISTED
Investcorp Europe Acquisition Corp I Warrant
IVCBW
$229K ﹤0.01%
1,000,000
SCRMW
789
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$222K ﹤0.01%
492,655
FET icon
790
Forum Energy Technologies
FET
$846M
$222K ﹤0.01%
10,000
UHGWW
791
DELISTED
United Homes Group Warrant
UHGWW
$193K ﹤0.01%
200,000
RVMDW icon
792
Revolution Medicines Inc Warrant
RVMDW
$117M
$165K ﹤0.01%
+500,000
New +$223K
CMTL icon
793
Comtech Telecommunications
CMTL
$51.5M
$156K ﹤0.01%
18,499
LCAAW
794
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
$112K ﹤0.01%
166,666
LNZAW icon
795
LanzaTech Global Warrant
LNZAW
$3.65M
$94.9K ﹤0.01%
192,500
-150,000
-44% -$76.3K
NINE
796
DELISTED
Nine Energy Service
NINE
$93.8K ﹤0.01%
35,000
-35,000
-50% -$101K
MDVL
797
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$89.8K ﹤0.01%
20,000
BFAC.WS
798
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
$75K ﹤0.01%
750,000
BAERW icon
799
Bridger Aerospace Warrant
BAERW
$10.9M
$72.2K ﹤0.01%
341,666
-25,000
-7% -$5.33K
NEXI
800
DELISTED
NexImmune, Inc. Common Stock
NEXI
$71.2K ﹤0.01%
32,054
-1
-0% -$3

Similar funds

Adage Capital Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Adage Capital Partners held 973 positions worth $48.3B, up 9.5% from $44.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Adage Capital Partners's Q4 2023 filing shows 114 new, 273 increased, 385 reduced and 131 closed positions. Its largest new stake was Uber: 2,148,900 shares worth $132M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q4 2023 buy was Uber: 2,148,900 shares worth $132M.
  • Adage Capital Partners added most to Hess in Q4 2023, an estimated $516M increase.
  • Adage Capital Partners's biggest Q4 2023 reduction was lululemon athletica, cutting an estimated $124M.
  • Adage Capital Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $340M.
  • Adage Capital Partners's ten largest holdings make up 25% of its $48.3B portfolio in Q4 2023.
  • Adage Capital Partners opened 114 new positions and closed 131 in Q4 2023.
  • Adage Capital Partners's portfolio value rose 9.5% quarter-over-quarter to $48.3B.

Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.